X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (982) 982
Publication (142) 142
Newspaper Article (85) 85
Conference Proceeding (9) 9
Book Chapter (5) 5
Book Review (5) 5
Book / eBook (3) 3
Magazine Article (2) 2
Dissertation (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (333) 333
humans (290) 290
male (193) 193
female (190) 190
adult (115) 115
middle aged (111) 111
hematology (110) 110
animals (100) 100
aged (92) 92
oncology (85) 85
research (84) 84
analysis (82) 82
adolescent (66) 66
brazil (64) 64
article (57) 57
multidisciplinary sciences (54) 54
cancer (53) 53
medicine (53) 53
health aspects (52) 52
young adult (48) 48
child (47) 47
research article (46) 46
studies (42) 42
care and treatment (41) 41
risk factors (40) 40
parasitology (39) 39
aged, 80 and over (38) 38
ophthalmology (38) 38
genetic aspects (37) 37
leukemia (37) 37
immunology (36) 36
microbiology (36) 36
therapy (36) 36
treatment outcome (36) 36
leukemia, myeloid, acute - genetics (35) 35
prognosis (35) 35
science (35) 35
mutation (34) 34
tropical medicine (34) 34
diagnosis (33) 33
epidemiology (32) 32
leukemia, myeloid, acute - drug therapy (32) 32
mice (31) 31
acute myeloid leukemia (30) 30
patients (30) 30
transplantation (29) 29
biology (28) 28
chemotherapy (28) 28
survival (28) 28
usage (28) 28
gene expression (27) 27
physiological aspects (27) 27
child, preschool (26) 26
disease (26) 26
life sciences (26) 26
plant sciences (26) 26
rats (26) 26
apoptosis (25) 25
expression (25) 25
leukemia, myeloid, acute - mortality (25) 25
medicine and health sciences (25) 25
pathology (25) 25
prevalence (25) 25
risk (25) 25
glaucoma (24) 24
ecology (23) 23
infections (23) 23
infectious diseases (23) 23
biology and life sciences (22) 22
cells (22) 22
proteins (22) 22
acute myeloid-leukemia (21) 21
aml (21) 21
brazil - epidemiology (21) 21
pharmacology & pharmacy (21) 21
abridged index medicus (20) 20
cell biology (20) 20
dentistry (20) 20
infection (20) 20
medicine & public health (20) 20
medicine, research & experimental (20) 20
methods (20) 20
public, environmental & occupational health (20) 20
remission induction (20) 20
stem cells (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
genes (19) 19
genetic structures (19) 19
inflammation (19) 19
mortality (19) 19
nursing (19) 19
surgery (19) 19
age (18) 18
bacteria (18) 18
environmental sciences (18) 18
medical research (18) 18
obesity (18) 18
original (18) 18
physics (18) 18
physiology (18) 18
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 12/2013, Volume 73, Issue 24 Supplement, pp. OT3-2-11 - OT3-2-11
Journal Article
Blood, ISSN 0006-4971, 08/2018, Volume 132, Issue 7, pp. 676 - 678
Inability to provide transfusion support to patients with leukemia is a major cause of delays in hospice enrollment for end-of-life (EOL) care. In this issue... 
HEMATOLOGY | ACUTE MYELOID-LEUKEMIA | OUTCOMES | Terminal Care | Platelet Transfusion | Hospices | Humans | Leukemia
Journal Article
Best Practice & Research Clinical Haematology, ISSN 1521-6926, 12/2018, Volume 31, Issue 4, pp. 384 - 386
Despite advances in treatment for acute myeloid leukemia (AML), the prognosis for patients with relapsed disease is extremely poor. The median overall survival... 
AML | Refractory | Relapse | Enasidenib | Ivosidenib | Quizartinib | Acute myeloid leukemia | Gemtuzumab ozogamicin | Gilteritinib | ADULT PATIENTS | PLUS CYTARABINE | ACUTE MYELOID-LEUKEMIA | HEMATOLOGY | Leukemia | Diseases
Journal Article
Leukemia Research, ISSN 0145-2126, 10/2018, Volume 73, pp. 39 - 40
Journal Article
Leukemia Research, ISSN 0145-2126, 05/2018, Volume 68, pp. 32 - 39
Treatment regimens for acute myeloid leukemia (AML) have remained largely unchanged until recently. Molecular advances have opened the door to targeted... 
AML | Clinical trial | Endpoint | Leukemia | DIAGNOSIS | PART I | FREE SURVIVAL | SUBGROUP ANALYSES | CANCER | CHEMOTHERAPY | ONCOLOGY | RECOMMENDATIONS | DISEASE | OUTCOMES | HEMATOLOGY | Medical colleges | Transplantation | Stem cells
Journal Article
Haematologica, ISSN 0390-6078, 07/2017, Volume 102, Issue 8, pp. 1301 - 1303
Journal Article
BLOOD, ISSN 0006-4971, 03/2012, Volume 119, Issue 9, pp. 1958 - 1959
In acute myeloid leukemia (AML), cytogenetic abnormalities are present in more than half of patients and these chromosomal alterations are critical factors... 
PROGNOSTIC IMPACT | GENETIC INSTABILITY | MONOSOMAL KARYOTYPE | CANCER MUTANTS | LEUKEMIA | HEMATOLOGY | ADULT | GAIN
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 5, pp. 454 - 464
Midostaurin, an oral multitargeted kinase inhibitor, is active in patients with a FLT3 mutation. Among patients with acute myeloid leukemia and this mutation,... 
TRIAL | INTERNAL TANDEM DUPLICATION | WILD-TYPE | MEDICINE, GENERAL & INTERNAL | FAVORABLE PROGNOSIS | ACUTE MYELOGENOUS LEUKEMIA | DISTINCT | TYROSINE KINASE INHIBITOR | SORAFENIB | PHASE-I | YOUNGER | Humans | Middle Aged | Kaplan-Meier Estimate | Staurosporine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Staurosporine - analogs & derivatives | Protein Kinase Inhibitors - adverse effects | Cytarabine - administration & dosage | Leukemia, Myeloid, Acute - mortality | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Mutation | Daunorubicin - administration & dosage | Leukemia, Myeloid, Acute - genetics | Staurosporine - administration & dosage | Chemotherapy | Care and treatment | Myelocytic leukemia | Nonlymphoid leukemia | Research | Drug therapy | Cancer | Tyrosine | Medical research | Inhibitor drugs | Myeloid leukemia | Leukemia | Clinical trials | Oncology | Transplantation | Kinases | Patients | Cancer therapies | Survival | Cytarabine | Daunorubicin | Medical prognosis | Point mutation | Death | Remission | Acute myeloid leukemia | Protein-tyrosine kinase | Drug dosages
Journal Article
Blood, ISSN 0006-4971, 09/2010, Volume 116, Issue 13, pp. 2224 - 2228
Journal Article
LEUKEMIA, ISSN 0887-6924, 12/2012, Volume 26, Issue 12, pp. 2530 - 2537
Multiple myeloma is a hematological neoplasm characterized by the accumulation of clonal plasma cells in the bone marrow. Its frequent relapse following... 
multiple myeloma | BONE-MARROW | CORD BLOOD | SELF-RENEWAL | xenotransplantation | MODEL | IDENTIFICATION | CANCER STEM-CELLS | TUMOR-INITIATING CELLS | B-CELLS | myeloma-initiating cells | ONCOLOGY | SCID-HU MICE | HEMATOLOGY | HUMAN MULTIPLE-MYELOMA
Journal Article
Blood, ISSN 0006-4971, 08/2017, Volume 130, Issue 6, pp. 722 - 731
Journal Article
Journal Article